Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

SGRY vs AMSF vs KNTK vs USPH vs SEM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SGRY
Surgery Partners, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.87B
5Y Perf.+6.8%
AMSF
AMERISAFE, Inc.

Insurance - Specialty

Financial ServicesNASDAQ • US
Market Cap$569M
5Y Perf.-50.6%
KNTK
Kinetik Holdings Inc.

Oil & Gas Midstream

EnergyNASDAQ • US
Market Cap$3.33B
5Y Perf.+602.3%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%
SEM
Select Medical Holdings Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$2.04B
5Y Perf.+89.2%

SGRY vs AMSF vs KNTK vs USPH vs SEM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SGRY logoSGRY
AMSF logoAMSF
KNTK logoKNTK
USPH logoUSPH
SEM logoSEM
IndustryMedical - Care FacilitiesInsurance - SpecialtyOil & Gas MidstreamMedical - Care FacilitiesMedical - Care Facilities
Market Cap$1.87B$569M$3.33B$897M$2.04B
Revenue (TTM)$3.34B$325M$1.73B$695M$5.52B
Net Income (TTM)$-76M$46M$228M$11M$134M
Gross Margin22.8%47.6%24.8%22.0%10.6%
Operating Margin11.8%17.8%8.2%12.2%5.8%
Forward P/E38.0x14.4x42.4x20.6x13.1x
Total Debt$4.02B$491K$3.87B$426M$3.70B
Cash & Equiv.$240M$62M$4M$36M$27M

SGRY vs AMSF vs KNTK vs USPH vs SEMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SGRY
AMSF
KNTK
USPH
SEM
StockMay 20May 26Return
Surgery Partners, I… (SGRY)100106.8+6.8%
AMERISAFE, Inc. (AMSF)10049.4-50.6%
Kinetik Holdings In… (KNTK)100702.3+602.3%
U.S. Physical Thera… (USPH)10079.6-20.4%
Select Medical Hold… (SEM)100189.2+89.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: SGRY vs AMSF vs KNTK vs USPH vs SEM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AMSF and KNTK are tied at the top with 3 categories each (5-stock set) — the right choice depends on your priorities. Kinetik Holdings Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. SEM also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
SGRY
Surgery Partners, Inc.
The Healthcare Pick

SGRY lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
AMSF
AMERISAFE, Inc.
The Insurance Pick

AMSF carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.

  • Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
  • Beta 0.23, yield 8.4%, current ratio 0.32x
  • 14.3% margin vs SGRY's -2.3%
  • Beta 0.23 vs SGRY's 1.04, lower leverage
Best for: sleep-well-at-night and defensive
KNTK
Kinetik Holdings Inc.
The Income Pick

KNTK is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 3 yrs, beta 0.60, yield 16.5%
  • Rev growth 19.0%, EPS growth 157.8%, 3Y rev CAGR 13.3%
  • 19.0% revenue growth vs AMSF's 2.6%
  • 16.5% yield, 3-year raise streak, vs USPH's 3.1%, (1 stock pays no dividend)
Best for: income & stability and growth exposure
USPH
U.S. Physical Therapy, Inc.
The Income Angle

Among these 5 stocks, USPH doesn't own a clear edge in any measured category.

Best for: healthcare exposure
SEM
Select Medical Holdings Corporation
The Long-Run Compounder

SEM ranks third and is worth considering specifically for long-term compounding.

  • 158.5% 10Y total return vs AMSF's 31.8%
  • Lower P/E (13.1x vs 20.6x)
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthKNTK logoKNTK19.0% revenue growth vs AMSF's 2.6%
ValueSEM logoSEMLower P/E (13.1x vs 20.6x)
Quality / MarginsAMSF logoAMSF14.3% margin vs SGRY's -2.3%
Stability / SafetyAMSF logoAMSFBeta 0.23 vs SGRY's 1.04, lower leverage
DividendsKNTK logoKNTK16.5% yield, 3-year raise streak, vs USPH's 3.1%, (1 stock pays no dividend)
Momentum (1Y)KNTK logoKNTK+28.0% vs SGRY's -38.2%
Efficiency (ROA)AMSF logoAMSF5.6% ROA vs SGRY's -0.9%, ROIC 21.9% vs 4.1%

SGRY vs AMSF vs KNTK vs USPH vs SEM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SGRYSurgery Partners, Inc.
FY 2025
Healthcare Organization, Patient Service
49.4%$3.2B
Private Insurance
25.8%$1.7B
Government Revenue
21.1%$1.4B
Self-Pay Revenue
1.3%$88M
Other Services
1.3%$82M
Other Patient Service Revenue Sources
1.1%$71M
AMSFAMERISAFE, Inc.

Segment breakdown not available.

KNTKKinetik Holdings Inc.
FY 2025
Natural Gas, NGLs and Condensate Sales
74.1%$1.3B
Gathering and Processing Services
25.2%$445M
Product and Service, Other
0.7%$12M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
SEMSelect Medical Holdings Corporation
FY 2025
Health Care, Patient Service, Non-Medicare
61.5%$3.4B
Health Care, Patient Service, Medicare
28.6%$1.6B
Service, Other
9.9%$538M

SGRY vs AMSF vs KNTK vs USPH vs SEM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAMSFLAGGINGUSPH

Income & Cash Flow (Last 12 Months)

AMSF leads this category, winning 4 of 6 comparable metrics.

SEM is the larger business by revenue, generating $5.5B annually — 17.0x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to SGRY's -2.3%. On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSGRY logoSGRYSurgery Partners,…AMSF logoAMSFAMERISAFE, Inc.KNTK logoKNTKKinetik Holdings …USPH logoUSPHU.S. Physical The…SEM logoSEMSelect Medical Ho…
RevenueTrailing 12 months$3.3B$325M$1.7B$695M$5.5B
EBITDAEarnings before interest/tax$572M$58M$534M$107M$465M
Net IncomeAfter-tax profit-$76M$46M$228M$11M$134M
Free Cash FlowCash after capex$208M$8M$441M$67M$117M
Gross MarginGross profit ÷ Revenue+22.8%+47.6%+24.8%+22.0%+10.6%
Operating MarginEBIT ÷ Revenue+11.8%+17.8%+8.2%+12.2%+5.8%
Net MarginNet income ÷ Revenue-2.3%+14.3%+13.2%+1.5%+2.4%
FCF MarginFCF ÷ Revenue+6.2%+2.5%+25.5%+9.6%+2.1%
Rev. Growth (YoY)Latest quarter vs prior year+4.5%+10.3%-7.5%+7.7%+5.0%
EPS Growth (YoY)Latest quarter vs prior year+6.7%-8.5%-2.4%-115.0%-18.2%
AMSF leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SEM leads this category, winning 3 of 6 comparable metrics.

At 12.3x trailing earnings, AMSF trades at a 70% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than KNTK's 13.1x.

MetricSGRY logoSGRYSurgery Partners,…AMSF logoAMSFAMERISAFE, Inc.KNTK logoKNTKKinetik Holdings …USPH logoUSPHU.S. Physical The…SEM logoSEMSelect Medical Ho…
Market CapShares × price$1.9B$569M$3.3B$897M$2.0B
Enterprise ValueMkt cap + debt − cash$5.7B$508M$7.2B$1.3B$5.7B
Trailing P/EPrice ÷ TTM EPS-23.46x12.27x18.43x41.55x13.93x
Forward P/EPrice ÷ next-FY EPS est.37.99x14.42x42.44x20.63x13.06x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple10.00x8.53x13.14x12.52x12.04x
Price / SalesMarket cap ÷ Revenue0.57x1.80x1.89x1.15x0.37x
Price / BookPrice ÷ Book value/share0.52x2.30x1.04x1.16x1.00x
Price / FCFMarket cap ÷ FCF9.57x63.83x44.78x14.71x5.33x
SEM leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

AMSF leads this category, winning 7 of 9 comparable metrics.

KNTK delivers a 21.1% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-2 for SGRY. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEM's 1.82x. On the Piotroski fundamental quality scale (0–9), AMSF scores 7/9 vs KNTK's 4/9, reflecting strong financial health.

MetricSGRY logoSGRYSurgery Partners,…AMSF logoAMSFAMERISAFE, Inc.KNTK logoKNTKKinetik Holdings …USPH logoUSPHU.S. Physical The…SEM logoSEMSelect Medical Ho…
ROE (TTM)Return on equity-2.2%+9.7%+21.1%+1.4%+6.6%
ROA (TTM)Return on assets-0.9%+5.6%+4.2%+0.9%+2.3%
ROICReturn on invested capital+4.1%+21.9%+1.9%+5.6%+4.8%
ROCEReturn on capital employed+5.2%+16.8%+2.5%+7.6%+7.0%
Piotroski ScoreFundamental quality 0–957455
Debt / EquityFinancial leverage1.14x0.00x1.32x0.55x1.82x
Net DebtTotal debt minus cash$3.8B-$61M$3.9B$390M$3.7B
Cash & Equiv.Liquid assets$240M$62M$4M$36M$27M
Total DebtShort + long-term debt$4.0B$491,000$3.9B$426M$3.7B
Interest CoverageEBIT ÷ Interest expense1.35x5.98x15.42x4.41x
AMSF leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

KNTK leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in KNTK five years ago would be worth $19,312 today (with dividends reinvested), compared to $2,773 for SGRY. Over the past 12 months, KNTK leads with a +28.0% total return vs SGRY's -38.2%. The 3-year compound annual growth rate (CAGR) favors KNTK at 24.7% vs SGRY's -25.8% — a key indicator of consistent wealth creation.

MetricSGRY logoSGRYSurgery Partners,…AMSF logoAMSFAMERISAFE, Inc.KNTK logoKNTKKinetik Holdings …USPH logoUSPHU.S. Physical The…SEM logoSEMSelect Medical Ho…
YTD ReturnYear-to-date-6.2%-18.3%+37.4%-24.6%+11.4%
1-Year ReturnPast 12 months-38.2%-29.2%+28.0%-14.3%+11.1%
3-Year ReturnCumulative with dividends-59.2%-24.8%+93.9%-43.7%+7.4%
5-Year ReturnCumulative with dividends-72.3%-18.9%+93.1%-43.4%-11.1%
10-Year ReturnCumulative with dividends-0.6%+31.8%-33.5%+22.6%+158.5%
CAGR (3Y)Annualised 3-year return-25.8%-9.1%+24.7%-17.4%+2.4%
KNTK leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AMSF and SEM each lead in 1 of 2 comparable metrics.

AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than SGRY's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.8% from its 52-week high vs SGRY's 59.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSGRY logoSGRYSurgery Partners,…AMSF logoAMSFAMERISAFE, Inc.KNTK logoKNTKKinetik Holdings …USPH logoUSPHU.S. Physical The…SEM logoSEMSelect Medical Ho…
Beta (5Y)Sensitivity to S&P 5001.04x0.23x0.60x0.93x0.46x
52-Week HighHighest price in past year$24.18$48.54$51.11$93.50$16.99
52-Week LowLowest price in past year$11.41$29.42$31.33$58.55$11.65
% of 52W HighCurrent price vs 52-week peak+59.2%+62.4%+94.8%+63.1%+96.8%
RSI (14)Momentum oscillator 0–10063.334.251.346.160.9
Avg Volume (50D)Average daily shares traded1.5M212K1.2M171K2.1M
Evenly matched — AMSF and SEM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KNTK and USPH each lead in 1 of 2 comparable metrics.

Analyst consensus: SGRY as "Buy", AMSF as "Buy", KNTK as "Buy", USPH as "Buy", SEM as "Hold". Consensus price targets imply 72.9% upside for USPH (target: $102) vs -1.8% for KNTK (target: $48). For income investors, KNTK offers the higher dividend yield at 16.47% vs SEM's 1.55%.

MetricSGRY logoSGRYSurgery Partners,…AMSF logoAMSFAMERISAFE, Inc.KNTK logoKNTKKinetik Holdings …USPH logoUSPHU.S. Physical The…SEM logoSEMSelect Medical Ho…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyHold
Price TargetConsensus 12-month target$18.60$44.50$47.57$102.00$18.00
# AnalystsCovering analysts226151213
Dividend YieldAnnual dividend ÷ price+8.4%+16.5%+3.1%+1.5%
Dividend StreakConsecutive years of raises00350
Dividend / ShareAnnual DPS$2.55$7.98$1.80$0.25
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.1%+5.3%+0.6%+4.9%
Evenly matched — KNTK and USPH each lead in 1 of 2 comparable metrics.
Key Takeaway

AMSF leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEM leads in 1 (Valuation Metrics). 2 tied.

Best OverallAMERISAFE, Inc. (AMSF)Leads 2 of 6 categories
Loading custom metrics...

SGRY vs AMSF vs KNTK vs USPH vs SEM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SGRY or AMSF or KNTK or USPH or SEM a better buy right now?

For growth investors, Kinetik Holdings Inc.

(KNTK) is the stronger pick with 19. 0% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Surgery Partners, Inc. (SGRY) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SGRY or AMSF or KNTK or USPH or SEM?

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — SGRY or AMSF or KNTK or USPH or SEM?

Over the past 5 years, Kinetik Holdings Inc.

(KNTK) delivered a total return of +93. 1%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: SEM returned +158. 5% versus KNTK's -33. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SGRY or AMSF or KNTK or USPH or SEM?

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus Surgery Partners, Inc. 's 1. 04β — meaning SGRY is approximately 352% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 182% for Select Medical Holdings Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — SGRY or AMSF or KNTK or USPH or SEM?

By revenue growth (latest reported year), Kinetik Holdings Inc.

(KNTK) is pulling ahead at 19. 0% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: Kinetik Holdings Inc. grew EPS 157. 8% year-over-year, compared to -28. 9% for Select Medical Holdings Corporation. Over a 3-year CAGR, KNTK leads at 13. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SGRY or AMSF or KNTK or USPH or SEM?

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus -2. 4% for Surgery Partners, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 6. 1% for SEM. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SGRY or AMSF or KNTK or USPH or SEM more undervalued right now?

On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.

1x forward P/E versus 42. 4x for Kinetik Holdings Inc. — 29. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — SGRY or AMSF or KNTK or USPH or SEM?

In this comparison, KNTK (16.

5% yield), AMSF (8. 4% yield), USPH (3. 1% yield), SEM (1. 5% yield) pay a dividend. SGRY does not pay a meaningful dividend and should not be held primarily for income.

09

Is SGRY or AMSF or KNTK or USPH or SEM better for a retirement portfolio?

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, SGRY: -0. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SGRY and AMSF and KNTK and USPH and SEM?

These companies operate in different sectors (SGRY (Healthcare) and AMSF (Financial Services) and KNTK (Energy) and USPH (Healthcare) and SEM (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SGRY is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; KNTK is a small-cap high-growth stock; USPH is a small-cap high-growth stock; SEM is a small-cap deep-value stock. AMSF, KNTK, USPH, SEM pay a dividend while SGRY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SGRY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 13%
Run This Screen
Stocks Like

AMSF

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

KNTK

Income & Dividend Stock

  • Sector: Energy
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 6.5%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

SEM

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SGRY and AMSF and KNTK and USPH and SEM on the metrics below

Revenue Growth>
%
(SGRY: 4.5% · AMSF: 10.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.